BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 25771846)

  • 1. The effect of enalapril on furosemide-activated renin-angiotensin-aldosterone system in healthy dogs.
    Lantis AC; Ames MK; Werre S; Atkins CE
    J Vet Pharmacol Ther; 2015 Oct; 38(5):513-7. PubMed ID: 25771846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of long-term treatment with enalapril or hydralazine on the renin-angiotensin-aldosterone system and fluid balance in dogs with naturally acquired mitral valve regurgitation.
    Häggström J; Hansson K; Karlberg BE; Kvart C; Madej A; Olsson K
    Am J Vet Res; 1996 Nov; 57(11):1645-52. PubMed ID: 8915446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting the urinary aldosterone-to-creatinine ratio in healthy dogs and dogs with naturally occurring myxomatous mitral valve disease.
    Galizzi A; Bagardi M; Stranieri A; Zanaboni AM; Malchiodi D; Borromeo V; Brambilla PG; Locatelli C
    BMC Vet Res; 2021 Jan; 17(1):15. PubMed ID: 33413406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the angiotensin converting enzyme (ACE) inhibitor, captopril, on the cardiovascular, endocrine, and renal responses to furosemide in conscious lambs.
    de Wildt SN; Smith FG
    Can J Physiol Pharmacol; 1997 Apr; 75(4):263-70. PubMed ID: 9196851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects.
    Blumenfeld JD; Sealey JE; Mann SJ; Bragat A; Marion R; Pecker MS; Sotelo J; August P; Pickering TG; Laragh JH
    Am J Hypertens; 1999 May; 12(5):451-9. PubMed ID: 10342782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of 8-week administration of enalapril plus additional 2-week administration of furosemide on heart rate and exocrine pancreas secretion in dogs].
    Niebergall-Roth E; Teyssen S; Weber T; Singer MV
    Berl Munch Tierarztl Wochenschr; 1996; 109(11-12):414-8. PubMed ID: 8999774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal and adrenal resistance against atrial natriuretic peptide in congestive heart failure: effect of angiotensin I-converting-enzyme inhibition.
    Wambach G; Schittenhelm U; Bönner G; Kaufmann W
    Cardiology; 1989; 76(6):418-27. PubMed ID: 2558792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of enalapril maleate on blood pressure, renin-angiotensin-aldosterone system, and peripheral sympathetic activity in essential hypertension.
    Cerasola G; Cottone S; D'Ignoto G; Grasso L; Carone MB; Carapelle E; Contorno A
    Clin Ther; 1987; 9(4):390-9. PubMed ID: 3038326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short term effects of acute inhibition of the angiotensin-converting enzyme on the renin-angiotensin system and plasma atrial natriuretic peptide in healthy dogs fed a low-sodium diet versus a normal-sodium diet.
    Koch J; Pedersen HD; Jensen AL; Flagstad A; Poulsen K; Bie P
    Zentralbl Veterinarmed A; 1994 Mar; 41(2):121-7. PubMed ID: 8091887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs.
    McCaa RE; Gillespie JB
    Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute and chronic effects of a novel dihydrobenzofuran analogue and enalapril on blood pressure and plasma and tissue angiotensin converting enzyme activity in the sodium deficient normotensive rat.
    Longman SD; Howlett DR
    Arzneimittelforschung; 1988 May; 38(5):678-82. PubMed ID: 2843192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of captopril and enalapril on tissue renin-angiotensin systems in experimental heart failure.
    Hirsch AT; Talsness CE; Smith AD; Schunkert H; Ingelfinger JR; Dzau VJ
    Circulation; 1992 Nov; 86(5):1566-74. PubMed ID: 1330361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of inhibition of the maternal renin-angiotensin system on maternal and fetal responses to drainage of fetal fluids.
    Lumbers ER; Bernasconi C; Burrell JH
    Can J Physiol Pharmacol; 1996 Aug; 74(8):973-82. PubMed ID: 8960388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection of the arterial internal elastic lamina by inhibition of the renin-angiotensin system in the rat.
    Huang W; Alhenc Gelas F; Osborne-Pellegrin MJ
    Circ Res; 1998 May; 82(8):879-90. PubMed ID: 9576107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discrepancy between renin mRNA and plasma renin level in angiotensin-converting enzyme inhibitor-treated rats.
    Morishita R; Higaki J; Nagano M; Nakamura F; Tomita N; Zhao Y; Mikami H; Miyazaki M; Ogihara T
    Clin Exp Pharmacol Physiol; 1993 Jan; 20(1):15-20. PubMed ID: 8381736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin I-converting enzyme inhibition but not angiotensin II suppression alters angiotensin I-converting enzyme gene expression in vessels and epithelia.
    Costerousse O; Allegrini J; Clozel JP; Ménard J; Alhenc-Gelas F
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1180-7. PubMed ID: 9495881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes of angiotensin converting enzyme (ACE) levels during activation of the renin-angiotensin-aldosterone system (RAAs).
    Novo S; Adamo L; Giamporcaro A; Forte G; Longo B; Gallo VB; Licata G; Strano A
    Agents Actions Suppl; 1987; 22():339-47. PubMed ID: 2829597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of angiotensin-converting enzyme inhibition on renal adaptations to acute furosemide administration in conscious rats.
    Bak M; Shalmi M; Petersen JS; Poulsen LB; Christensen S
    J Pharmacol Exp Ther; 1993 Jul; 266(1):33-40. PubMed ID: 8392557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the oral angiotensin II receptor antagonist UP 269-6 or enalapril 20 mg on blood pressure and neurohormonal effects in salt-deplete man.
    McIntyre M; MacFadyen RJ; Meredith PA; Menard J; Brunner HR; Insuasty J; Reid JL
    J Cardiovasc Pharmacol; 1995 Jun; 25(6):994-1000. PubMed ID: 7564347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of cardiovascular structural changes when treating essential hypertension. The importance of the renin-angiotensin-aldosterone system.
    Dahlöf B; Herlitz H; Aurell M; Hansson L
    Am J Hypertens; 1992 Dec; 5(12 Pt 1):900-11. PubMed ID: 1337459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.